Literature DB >> 19928070

Modeling acute and chronic hypoxia using serial images of 18F-FMISO PET.

Kelin Wang1, Ellen Yorke, Sadek A Nehmeh, John L Humm, C Clifton Ling.   

Abstract

PURPOSE: Two types of tumor hypoxia most likely exist in human cancers: Chronic hypoxia due to the paucity of blood capillaries and acute hypoxia due to temporary shutdoWn of microvasculatures or fluctuation in the red cell flux. In a recent hypoxia imaging study using 18F-FMISO PET, the authors observed variation in tracer uptake in two sequential images and hypothesized that variation in acute hypoxia may be the cause. In this study, they develop an iterative optimization method to delineate chronic and acute hypoxia based on the 18F-FMISO PET serial images.
METHODS: They assume that (1) chronic hypoxia is the same in the two scans and can be represented by a Gaussian distribution, while (2) acute hypoxia varies in the two scans and can be represented by Poisson distributions. For validation, they used Monte Carlo simulations to generate pairs of 18F-FMISO PET images with known proportion of chronic and acute hypoxia and then applied the optimization method to the simulated serial images, yielding excellent fit between the input and the fitted results. They then applied this method to the serial 18F-FMISO PET images of 14 patients with head and neck cancers.
RESULTS: The results show good fit of the chronic hypoxia to Gaussian distributions for 13 out of 14 patients (with R2>0.7). Similarly, acute hypoxia appears to be well described by the Poisson distribution (R2>0.7) with three exceptions. The model calculation yielded the amount of acute hypoxia, which differed among the patients, ranging from approximately 13% to 52%, with an average of approximately 34%.
CONCLUSIONS: This is the first effort to separate acute and chronic hypoxia from serial PET images of cancer patients.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19928070      PMCID: PMC2852451          DOI: 10.1118/1.3213092

Source DB:  PubMed          Journal:  Med Phys        ISSN: 0094-2405            Impact factor:   4.071


  31 in total

Review 1.  Towards multidimensional radiotherapy (MD-CRT): biological imaging and biological conformality.

Authors:  C C Ling; J Humm; S Larson; H Amols; Z Fuks; S Leibel; J A Koutcher
Journal:  Int J Radiat Oncol Biol Phys       Date:  2000-06-01       Impact factor: 7.038

2.  Radiobiological and immunohistochemical assessment of hypoxia in human melanoma xenografts: acute and chronic hypoxia in individual tumours.

Authors:  E K Rofstad; K Måseide
Journal:  Int J Radiat Biol       Date:  1999-11       Impact factor: 2.694

3.  Multiple regions-of-interest analysis of setup uncertainties for head-and-neck cancer radiotherapy.

Authors:  Lifei Zhang; Adam S Garden; Justin Lo; K Kian Ang; Anesa Ahamad; William H Morrison; David I Rosenthal; Mark S Chambers; X Ronald Zhu; Radhe Mohan; Lei Dong
Journal:  Int J Radiat Oncol Biol Phys       Date:  2006-04-01       Impact factor: 7.038

4.  The role of vessel maturation and vessel functionality in spontaneous fluctuations of T2*-weighted GRE signal within tumors.

Authors:  Christine Baudelet; Greg O Cron; Réginald Ansiaux; Nathalie Crokart; Julie DeWever; Olivier Feron; Bernard Gallez
Journal:  NMR Biomed       Date:  2006-02       Impact factor: 4.044

5.  Therapeutic targets in radiotherapy.

Authors:  J M Brown
Journal:  Int J Radiat Oncol Biol Phys       Date:  2001-02-01       Impact factor: 7.038

6.  Fluctuations in tumor blood perfusion assessed by dynamic contrast-enhanced MRI.

Authors:  Kjetil G Brurberg; Ilana C Benjaminsen; Liv M R Dørum; Einar K Rofstad
Journal:  Magn Reson Med       Date:  2007-09       Impact factor: 4.668

7.  Comparison of Helzel and OxyLite systems in the measurements of tumor partial oxygen pressure (pO2).

Authors:  Bixiu Wen; Muneyasu Urano; John L Humm; Venkatraman E Seshan; Gloria C Li; C Clifton Ling
Journal:  Radiat Res       Date:  2008-01       Impact factor: 2.841

8.  Fluorine-18-labeled fluoromisonidazole positron emission and computed tomography-guided intensity-modulated radiotherapy for head and neck cancer: a feasibility study.

Authors:  Nancy Y Lee; James G Mechalakos; Sadek Nehmeh; Zhixiong Lin; Olivia D Squire; Shangde Cai; Kelvin Chan; Pasquale B Zanzonico; Carlo Greco; Clifton C Ling; John L Humm; Heiko Schöder
Journal:  Int J Radiat Oncol Biol Phys       Date:  2007-09-14       Impact factor: 7.038

9.  Immunohistochemical detection of changes in tumor hypoxia.

Authors:  James Russell; Sean Carlin; Sean A Burke; Bixiu Wen; Kwang Mo Yang; C Clifton Ling
Journal:  Int J Radiat Oncol Biol Phys       Date:  2009-03-15       Impact factor: 7.038

10.  Reproducibility of intratumor distribution of (18)F-fluoromisonidazole in head and neck cancer.

Authors:  Sadek A Nehmeh; Nancy Y Lee; Heiko Schröder; Olivia Squire; Pat B Zanzonico; Yusuf E Erdi; Carlo Greco; Gig Mageras; Hai S Pham; Steve M Larson; Clifton C Ling; John L Humm
Journal:  Int J Radiat Oncol Biol Phys       Date:  2008-01-01       Impact factor: 7.038

View more
  13 in total

1.  Low-field magnetic resonance imaging to visualize chronic and cycling hypoxia in tumor-bearing mice.

Authors:  Hironobu Yasui; Shingo Matsumoto; Nallathamby Devasahayam; Jeeva P Munasinghe; Rajani Choudhuri; Keita Saito; Sankaran Subramanian; James B Mitchell; Murali C Krishna
Journal:  Cancer Res       Date:  2010-07-20       Impact factor: 12.701

Review 2.  Acute versus chronic hypoxia in tumors: Controversial data concerning time frames and biological consequences.

Authors:  C Bayer; P Vaupel
Journal:  Strahlenther Onkol       Date:  2012-03-29       Impact factor: 3.621

3.  Intra- and intertumor heterogeneities in total, chronic, and acute hypoxia in xenografted squamous cell carcinomas. Detection and quantification using (immuno-)fluorescence techniques.

Authors:  C-A Maftei; C Bayer; K Shi; P Vaupel
Journal:  Strahlenther Onkol       Date:  2012-06-14       Impact factor: 3.621

4.  PET hypoxia imaging with FAZA: reproducibility at baseline and during fractionated radiotherapy in tumour-bearing mice.

Authors:  M Busk; L S Mortensen; M Nordsmark; J Overgaard; S Jakobsen; K V Hansen; J Theil; J F Kallehauge; F P D'Andrea; T Steiniche; M R Horsman
Journal:  Eur J Nucl Med Mol Imaging       Date:  2012-10-18       Impact factor: 9.236

5.  Principal component analysis enhances SNR for dynamic electron paramagnetic resonance oxygen imaging of cycling hypoxia in vivo.

Authors:  Gage Redler; Boris Epel; Howard J Halpern
Journal:  Magn Reson Med       Date:  2013-02-07       Impact factor: 4.668

6.  Noninvasive Imaging of Cycling Hypoxia in Head and Neck Cancer Using Intrinsic Susceptibility MRI.

Authors:  Rafal Panek; Liam Welsh; Lauren C J Baker; Maria A Schmidt; Kee H Wong; Angela M Riddell; Dow-Mu Koh; Alex Dunlop; Dualta Mcquaid; James A d'Arcy; Shreerang A Bhide; Kevin J Harrington; Christopher M Nutting; Georgina Hopkinson; Cheryl Richardson; Carol Box; Suzanne A Eccles; Martin O Leach; Simon P Robinson; Kate L Newbold
Journal:  Clin Cancer Res       Date:  2017-03-17       Impact factor: 12.531

Review 7.  Hypoxia in Head and Neck Tumors: Characteristics and Development during Therapy.

Authors:  Martin-Immanuel Bittner; Anca-Ligia Grosu
Journal:  Front Oncol       Date:  2013-08-28       Impact factor: 6.244

Review 8.  Imaging tumour hypoxia with positron emission tomography.

Authors:  I N Fleming; R Manavaki; P J Blower; C West; K J Williams; A L Harris; J Domarkas; S Lord; C Baldry; F J Gilbert
Journal:  Br J Cancer       Date:  2014-12-16       Impact factor: 7.640

Review 9.  Hypoxia in head and neck cancer in theory and practice: a PET-based imaging approach.

Authors:  Loredana G Marcu; Wendy M Harriss-Phillips; Sanda M Filip
Journal:  Comput Math Methods Med       Date:  2014-08-21       Impact factor: 2.238

10.  Hypoxia Imaging With PET Correlates With Antitumor Activity of the Hypoxia-Activated Prodrug Evofosfamide (TH-302) in Rodent Glioma Models.

Authors:  Ashley M Stokes; Charles P Hart; C Chad Quarles
Journal:  Tomography       Date:  2016-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.